Does OXALIPLATIN Cause Diffuse large b-cell lymphoma refractory? 79 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 79 reports of Diffuse large b-cell lymphoma refractory have been filed in association with OXALIPLATIN (Oxaliplatin). This represents 0.1% of all adverse event reports for OXALIPLATIN.
79
Reports of Diffuse large b-cell lymphoma refractory with OXALIPLATIN
0.1%
of all OXALIPLATIN reports
15
Deaths
13
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma refractory From OXALIPLATIN?
Of the 79 reports, 15 (19.0%) resulted in death, 13 (16.5%) required hospitalization, and 11 (13.9%) were considered life-threatening.
Is Diffuse large b-cell lymphoma refractory Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OXALIPLATIN. However, 79 reports have been filed with the FAERS database.
What Other Side Effects Does OXALIPLATIN Cause?
Diarrhoea (4,963)
Nausea (4,250)
Neuropathy peripheral (3,662)
Off label use (3,603)
Neutropenia (3,391)
Vomiting (3,383)
Disease progression (3,370)
Thrombocytopenia (2,886)
Dyspnoea (2,779)
Pyrexia (2,269)
What Other Drugs Cause Diffuse large b-cell lymphoma refractory?
RITUXIMAB (461)
CYCLOPHOSPHAMIDE (360)
DOXORUBICIN (345)
VINCRISTINE (331)
ETOPOSIDE (244)
PREDNISONE (214)
EPCORITAMAB-BYSP (198)
CYTARABINE (193)
DEXAMETHASONE (170)
CISPLATIN (156)
Which OXALIPLATIN Alternatives Have Lower Diffuse large b-cell lymphoma refractory Risk?
OXALIPLATIN vs OXAPROZIN
OXALIPLATIN vs OXAZEPAM
OXALIPLATIN vs OXCARBAZEPINE
OXALIPLATIN vs OXITRIPTAN
OXALIPLATIN vs OXOMEMAZINE